Holen Sie sich die Stockscreener-App
3.39
0.59%
0.02
Schlusskurs vom Vortag:
$3.37
Offen:
$3.4
24-Stunden-Volumen:
143.23K
Relative Volume:
0.41
Marktkapitalisierung:
$40.56M
Einnahmen:
$12,000
Nettoeinkommen (Verlust:
$-48.50M
KGV:
-0.1986
EPS:
-17.0687
Netto-Cashflow:
$-19.78M
1W Leistung:
-14.61%
1M Leistung:
-13.30%
6M Leistung:
-71.46%
1J Leistung:
-49.78%
1-Tages-Spanne:
$3.29
$3.48
1-Wochen-Bereich:
$3.26
$4.01
52-Wochen-Spanne:
$2.49
$49.80
Incannex Healthcare Inc Stock (IXHL) Company Profile
Firmenname
Incannex Healthcare Inc
Sektor
Telefon
61 409 840 786
Adresse
8 CENTURY CIRCUIT, NORWEST NSW
Compare IXHL vs TAK, HLN, TEVA, ZTS, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IXHL
Incannex Healthcare Inc
|
3.39 | 40.56M | 12,000 | -48.50M | -19.78M | -17.07 |
TAK
Takeda Pharmaceutical Co Adr
|
16.56 | 52.88B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.76 | 42.98B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.95 | 38.37B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
75.56 | 31.68B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
547.06 | 23.22B | 3.17B | 1.29B | 1.01B | 27.09 |
Incannex Healthcare Inc Aktie (IXHL) Neueste Nachrichten
IXHL Q2 2026 Earnings: Significant EPS Miss as Pre-Revenue Biotech Ramps Up R&D SpendingCash Flow Report - dars.gov.et
Why Did IXHL Stock Tank Over 32% Today? - Stocktwits
Incannex Healthcare(IXHL) Stock Options Chain | Quotes & News - Moomoo
Incannex Healthcare (ASX:IHL): Why Is This Cannabis Innovator Back in Focus? - Kalkine Media
Price to earnings forward of Incannex Healthcare Inc. – NASDAQ:IXHL - TradingView
Tranche Update on Incannex Healthcare Inc.'s Equity Buyback Plan announced on August 22, 2025. - marketscreener.com
Sleep Apnea Market Expected to Experience Accelerated Growth and Market Evolution by 2034 – DelveInsight | Apnimed, Eli Lilly, Incannex Healthcare, Axsome Therapeutics, Jazz Pharma, Bioprojet - Barchart.com
Incannex Healthcare (IXHL) Stock Forecast & Analyst Ratings - Moomoo
IXHL Forecast — Price Target — Prediction for 2027 - TradingView
Neuropsychiatric medicine reaches an inflexion point: regulation, science and the road to commercial reality - Manufacturing Chemist
Incannex Healthcare Inc. Actuals & Estimates (NASDAQ:IXHL) - TradingView
Incannex Healthcare Inc (IXHL) Valuation: PE, PB & Fair Value Analysis - TradingKey
A2DF4D Forecast — Price Target — Prediction for 2027 - TradingView
Incannex receives U.S. patent for sleep apnea drug IHL-42X By Investing.com - Investing.com South Africa
Incannex receives U.S. patent for sleep apnea drug IHL-42X - Investing.com
Incannex Healthcare Receives US Patent for IHL-42X in Obstructive Sleep Apnea - marketscreener.com
Incannex Secures U.S. Patent Grant for IHL-42X in Obstructive Sleep Apnea - The Manila Times
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Incannex's sleep apnea drug gets U.S. patent protection to 2040 - Stock Titan
Incannex (IXHL) secures long-dated U.S. patent for IHL-42X sleep apnoea therapy - Stock Titan
Incannex Healthcare Inc (IXHL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Incannex Healthcare Inc (IXHL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Why Is Incannex (ASX:IHL) Emerging as a Clinical Cannabis Story? - Kalkine Media
IXHL Stock Rips To Best Day In 5 Months: Nasdaq Compliance Back In Sight As FDA Catalyst For Sleep Apnea Drug Looms - Stocktwits
Incannex Healthcare Inc (IXHL) Institutional Confidence - TradingKey
Incannex Healthcare Inc (IXHL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Incannex Healthcare (IXHL) Proxy Filing Summary - Quartr
Incannex Healthcare receives A$6m R&D tax incentive payment By Investing.com - Investing.com Nigeria
IXHL Stock Gains As Incannex Reactivates Share Repurchase Program - Stocktwits
IXHL Should I Buy - Intellectia AI
Incannex Healthcare Inc (IXHL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Incannex Healthcare Inc (IXHL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Incannex Healthcare Inc (IXHL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
IXHL Q1 2026 Earnings: Deep Earnings Miss Reflects Pre-Revenue Biotech ChallengesBalance Sheet Strength - dars.gov.et
$Incannex Healthcare (IXHL.US)$ - Moomoo
Incannex Healthcare receives A$6m R&D tax incentive payment - Investing.com UK
Incannex Healthcare Secures Major Non-Dilutive R&D Funding - TipRanks
Incannex Healthcare Secures Over A$11 Million in Non-Dilutive Capital Through Australian R&D Tax Incentive Program - Quiver Quantitative
Incannex Receives A$6.0 Million R&D Tax Incentive Refund for FY25, Further Strengthening Balance Sheet and Financial Flexibility - The Manila Times
Incannex lines up A$11m in non‑dilutive cash to advance IHL‑42X study - Stock Titan
Incannex Receives A$6.0M R&D Tax Refund, Expects A$11.1M+ in Non-Dilutive Funding - TradingView
Incannex (Nasdaq: IXHL) secures over A$11.1M in R&D tax incentives - Stock Titan
Incannex Healthcare: Target Price Consensus and Analysts Recommendations | IQI | AU000000IHL8 - marketscreener.com
Incannex Healthcare Gains Independent Buy-Rated Research Coverage - TipRanks
Sleep apnea and anxiety drug developer Incannex gets AGP buy rating at $18 - Stock Titan
Incannex Healthcare: Alliance Global Partners Starts Coverage with $18 Price Target - TradingView
Finanzdaten der Incannex Healthcare Inc-Aktie (IXHL)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.42%
0.81%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):